National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 13609-13610 [2025-05023]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 56 / Tuesday, March 25, 2025 / Notices
Place: National Institutes of Health, 6001
Executive Boulevard, Room 1131, Rockville,
Maryland 20852 (Virtual Meeting).
Contact Person: David Owens, Ph.D.,
Deputy Director, Extramural Activities
National Institute of Neurological, Disorders
and Stroke, NIH, 6001 Executive Blvd., 5th
Floor, MSC 9531, Bethesda, MD 20892, (301)
496–9248, owensd@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice at least 10 days in advance of the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05025 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Coordinating Center-JHS.
Date: April 28, 2025.
Time: 9:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate contract
proposals.
Address: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892.
Meeting Format: Virtual Meeting.
VerDate Sep<11>2014
18:03 Mar 24, 2025
Jkt 265001
Contact Person: Zhihong Shan, MD, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085, email:
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Community Engagement Center-JHS.
Date: April 28, 2025.
Time: 10:45 a.m. to 11:45 a.m.
Agenda: To review and evaluate contract
proposals.
Address: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Zhihong Shan, MD, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085, email:
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Field Center-JHS.
Date: April 28, 2025.
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Zhihong Shan, MD, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085, email:
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Training and Education Center-JHS.
Date: April 28, 2025.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Zhihong Shan, MD, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085, email:
zhihong.shan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 20, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05016 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
13609
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; HEAL Initiative:
Pain Research Enhancement Program (PREP)
(R15 Clinical Trial Optional).
Date: May 5, 2025.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for
Complementary and Integrative Health,
Democracy II, Suite 401, 6707 Democracy
Blvd., Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Michael E. Authement,
Ph.D., Scientific Review Officer, Office of
Scientific Review, Division of Extramural
Activities, 6707 Democracy Boulevard,
Bethesda, MD 20817, michael.authement@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: March 19, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05003 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
E:\FR\FM\25MRN1.SGM
25MRN1
13610
Federal Register / Vol. 90, No. 56 / Tuesday, March 25, 2025 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Fellowships in
Digestive Diseases and Nutrition.
Date: June 12–13, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7799, yangj@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05023 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Drug Abuse.
The meeting will be held as a virtual
meeting and is open to the public, as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance such as sign language
interpretation or other reasonable
accommodations to view the meeting,
should notify Dr. Gillian Acca via email
at gillian.acca@nih.gov five days in
advance of the meeting. The open
VerDate Sep<11>2014
18:03 Mar 24, 2025
Jkt 265001
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: May 13, 2025.
Closed: 11:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate grant
applications.
Open: 1:30 p.m. to 5:00 p.m.
Agenda: Presentations and other business
of the Council.
Meeting Format: Virtual Meeting.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Susan R.B. Weiss, Ph.D.,
Director, Division of Extramural Research,
Office of the Director, National Institute on
Drug Abuse, NIH, Three White Flint North,
RM 09D08, 11601 Landsdown Street,
Bethesda, MD 20852, 301–443–6480, sweiss@
nida.nih.gov.
Contact Person: Gillian Acca, Ph.D., Health
Scientist Administrator, Division of
Extramural Research, Office of Extramural
Policy, National Institute on Drug Abuse,
NIH, Three White Flint North, RM 09C70,
11601 Landsdown Street, Bethesda, MD
20852, 301–827–5863, gillian.acca@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to Dr. Gillian Acca via email
at gillian.acca@nih.gov. The statement
should include the name, address, telephone
number and when applicable, the business or
professional affiliation of the interested
person.
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: March 19, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–04981 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Altered Cell
Subtypes in Aging and AD/ADRD.
Date: April 8, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, National Institute
on Aging, National Institutes of Health, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892,
(301) 496–9667, email: prasadnb@
nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 20, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05008 Filed 3–24–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Council of Councils.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations, to view the meeting
should notify the Contact Person listed
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 90, Number 56 (Tuesday, March 25, 2025)]
[Notices]
[Pages 13609-13610]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05023]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
[[Page 13610]]
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Fellowships in Digestive
Diseases and Nutrition.
Date: June 12-13, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jian Yang, Ph.D., Scientific Review Officer,
National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, 6707 Democracy Boulevard, Bethesda,
MD 20892-5452, (301) 594-7799, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2025-05023 Filed 3-24-25; 8:45 am]
BILLING CODE 4140-01-P
